<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122701">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01916772</url>
  </required_header>
  <id_info>
    <org_study_id>CCFO7256</org_study_id>
    <nct_id>NCT01916772</nct_id>
  </id_info>
  <brief_title>Natural History of Cherubism Observational Study</brief_title>
  <official_title>Natural Hisotry of Cherubism Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the natural history of cherubism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will take a history and examine patients with cherubism to determine the
      natural history of the disease.  The investigators also may take skin or blood samples (IRB
      approved 7256) from patients to learn more about this disorder.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Disease progression</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will take a history and examine patients with cherubism and look for disease progression.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient growth</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will measure height and weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bone abnormalities</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will take panorex radiographs.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cherubism</condition>
  <arm_group>
    <arm_group_label>cherubism patients</arm_group_label>
    <description>no interventions</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no interventions</intervention_name>
    <description>no interventions</description>
    <arm_group_label>cherubism patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      We may take blood or skin samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We will see patients with cherubism
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        patients with cherubism

        Exclusion Criteria:

        patients without cherubism
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Steven Lietman</last_name>
    <phone>2168702475</phone>
    <email>lietmas@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven A Lietman, MD</last_name>
      <phone>216-445-2742</phone>
      <email>lietmas@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Steven A Lietman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lietman SA, Kalinchinko N, Deng X, Kohanski R, Levine MA. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation. Hum Mutat. 2006 Jul;27(7):717-8.</citation>
    <PMID>16786512</PMID>
  </reference>
  <reference>
    <citation>Fan C, Gaivin RJ, Marth TA, Willard B, Levine MA, Lietman SA. Cloning and characterization of the human SH3BP2 promoter. Biochem Biophys Res Commun. 2012 Aug 17;425(1):25-32. doi: 10.1016/j.bbrc.2012.07.043. Epub 2012 Jul 17.</citation>
    <PMID>22820184</PMID>
  </reference>
  <reference>
    <citation>Reichenberger EJ, Levine MA, Olsen BR, Papadaki ME, Lietman SA. The role of SH3BP2 in the pathophysiology of cherubism. Orphanet J Rare Dis. 2012 May 24;7 Suppl 1:S5. doi: 10.1186/1750-1172-7-S1-S5. Epub 2012 May 24. Review.</citation>
    <PMID>22640988</PMID>
  </reference>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 2, 2013</lastchanged_date>
  <firstreceived_date>July 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cherubism</keyword>
  <keyword>bone tumors</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cherubism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
